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acceptable with the 15-20 rule. The widest beta-expectation intervals despite 
fulfilled 15-20 rule were 38.1 to 55.5% at low concentrations (talinolol, 
assay V), 40.9 to 38.1% at medium concentrations (esmolol, assay V), and 
13.0 to 41.4% at high concentrations (9-HO-risperidone, assay IV).
Conclusion: Even in bioanalytical methods fulfilling the widely used 
 15-20 rule single measurements considerably deviating from the target value 
and hence causing problems in routine QC are not unlikely, especially if 
precision and bias values are close to the respective acceptance limits. 
Using the beta-expectation interval approach with a tolerance interval 
corresponding to routine QC limits, methods associated with a high risk of 
causing problems in routine QC can be more effectively identified during 
validation than with the 15-20 rule.
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Introduction: Consistent and efficient use of any analytical procedure 
requires the knowledge of its reliability prior to its use. It is therefore 
necessary for each laboratory to validate their analytical methods. Validation 
is not only required by regulatory authorities [ICH, FDA, GxP] or in order 
to access accreditation [ISO 17025], but is also the ultimate phase before 
the routine use of the method. Analytical method validation must bring 
confidence to the laboratories in the results that will be generated since 
they are used to make critical decision. However, very little information is 
included about the process and rules for making a decision – i.e. to reject 
or to accept an analytical method – with respect to its ability to achieve 
reliable results.
Aim: An innovative universal strategy using Total Error is thus proposed 
to decide about methods’ validity that controls the risk of accepting an 
unsuitable assay together with the ability to predict the reliability of future 
results. Several examples of applications of this validation methodology to 
various types of assays [LC-MS, ELISA, Bio-Assays] will be presented.
Method: Total error is the simultaneous combination of systematic (bias) 
and random (imprecision) error of analytical methods. Using validation 
standards both types of error are combined through the use of a prediction 
interval (β-expectation tolerance interval). Finally, an accuracy profile is built 
by connecting, on one hand all the upper tolerance limits, and on the other 
hand all the lower tolerance limits. This profile combined with pre-specified 
acceptance limits (e.g. 30% of bioanalysis) allows to evaluate the validity of 
any quantitative analytical method.
Results: The accuracy profile determines a region of results where a defined 
proportion of future measurements will be included inside the acceptance 
limits. If the analyst is willing to take, for example, a risk of 5%, this approach 
can give the laboratory as well as the regulatory authorities the guarantee 
that 95 times out of 100 the future measurements of unknown samples using 
the validated method will be included within the acceptance limits assessed 
according to the requirements. The accuracy profile is used to select the 
most appropriate standard curve, to estimate the limit(s) of quantification, 
to evaluate a potential matrix effect and, nonetheless provide estimates of 
measurement uncertainty.
Conclusions: This validation methodology approach allows the analysts as 
well as the regulatory bodies to know the risk to obtain future results out 
of the specified acceptance limit. Validation criteria such as the selection of 
the adequate standard curve and definition of the lower and upper limits of 
quantitation are straightforward and fit perfectly to their respective definition. 
Using the proposed approach, each analyst can predict the quality of the 
results that he will provide and thus earn confidence in the subsequent critical 
decisions made.
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Introduction: Ethylglucuronide (EtG) is a direct and specific metabolite 
of ethanol. Its determination in hair is of increasing interest for detecting 
and monitoring alcohol abuse. The quantification of EtG in hair requires 
analytical methods showing highest sensitivity and specificity. We present 
a fully validated method based on gas chromatography-negative chemical 
ionization tandem mass spectrometry (GC-NCI-MS/MS). The method was 
validated using French Society of Pharmaceutical Sciences and Techniques 
(SFSTP) guidelines which are based on the determination of the total 
measurement error and accuracy profiles. 
Methods: Washed and powdered hair is extracted in water using an ultrasonic 
incubation. After purification by Oasis MAX solid phase extraction, the 
derivatized EtG is detected and quantified by GC-NCI-MS/MS method in the 
selected reaction monitoring mode. The transitions m/z 347 / 163 and m/z 
347 / 119 were used for the quantification and identification of EtG. Four 
quality controls (QC) prepared with hair samples taken post mortem from 
2 subjects with a known history of alcoholism were used. A proficiency test 
with 7 participating laboratories was first run to validate the EtG concentration 
of each QC sample. Considering the results of this test, these samples were 
then used as internal controls for validation of the method.
Results: The mean EtG concentrations measured in the 4 QC were 
259.4, 130.4, 40.8, and 8.4 pg/mg hair. Method validation has shown 
linearity between 8.4 and 259.4 pg/mg hair (r2 > 0.999). The lower limit 
of quantification was set up at 8.4 pg/mg. Repeatability and intermediate 
precision were found less than 13.2% for all concentrations tested.
Conclusion: The method proved to be suitable for routine analysis of EtG in 
hair. GC-NCI-MS/MS method was then successfully applied to the analysis 
of EtG in hair samples collected from different alcohol consumers.
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Introduction: The screening for pharmaco/toxicologically relevant 
compounds (PTRC) in biosamples has benefited a lot from MS techniques. 
The library search approach has enabled the development of effective 
identification methods based on comparison of unknown and reference 
spectra. However, a downside of this approach is the limited number 
of reference mass spectra, particularly in the case of LC-MS where in-
house/commercial databases typically include not more than one thousand 
compounds. High mass resolution (HRMS) enables the identification of a 
molecular formula (MF) through the accurate measurement of mass and 
isotopic pattern. However, the identification of an unknown compound 
starting from MF requires additional tools: (a) a database associating MFs 
to compound names, and (b) a way to discriminate between compounds with 
identical MF. 
